Free Trial
NASDAQ:PETS

PetMed Express 4/15/2024 Earnings Report

PetMed Express logo
$3.24 +0.12 (+3.69%)
As of 01:10 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PetMed Express EPS Results

Actual EPS
-$0.10
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

PetMed Express Revenue Results

Actual Revenue
$65.32 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

PetMed Express Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

PetMed Express' Q4 2025 earnings is scheduled for Tuesday, August 5, 2025, with a conference call scheduled on Sunday, August 3, 2025 at 6:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

PetMed Express Earnings Headlines

Trump’s biggest move, misreported
The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada the 51st state because he’s desperate for critical minerals… They think his involvement in Ukraine is just another resource grab… They think his tariffs will wreck the economy… But they’re all missing the bigger picture.
Head to Head Comparison: PetMed Express (PETS) versus Its Peers
See More PetMed Express Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PetMed Express? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PetMed Express and other key companies, straight to your email.

About PetMed Express

PetMed Express (NASDAQ:PETS) (NASDAQ: PETS) operates as an online retailer specializing in pet medications and related products. Founded in 1996 and based in Delray Beach, Florida, the company was one of the first to offer prescription and non-prescription pharmaceuticals for dogs and cats through its PetsWarehouse.com and 1-800-PETMED e-commerce platforms. Over the years, PetMed Express has expanded its product assortment to encompass parasite preventives, dermatology treatments, supplements, and health-related accessories, catering to the evolving needs of pet owners.

The company’s core offerings include FDA-approved prescription medications for chronic conditions such as arthritis, allergies, and heart disease, as well as popular over-the-counter products for flea, tick and heartworm control. In addition to pharmaceuticals, PetMed Express stocks food, treats, vitamins, grooming supplies, and other wellness items sourced from leading brands. The business model emphasizes convenience, allowing customers to upload veterinary prescriptions, set up recurring shipments for maintenance therapies and access online resources on pet health topics.

While PetMed Express primarily serves the United States, it maintains a presence in Canada through cross-border fulfillment partnerships and helps customers navigate import regulations for prescription products. The company leverages a vertically integrated distribution network, including its FDA-inspected warehouses and call center, to streamline order processing, ensure product authenticity and offer customer support. PetMed Express also invests in digital marketing initiatives, mobile app enhancements and telehealth pilot programs to strengthen client engagement and capture share of the growing online pet care market.

Founded and led by industry veteran Stephen M. Duerr, PetMed Express has adhered to a mission of improving pet health through accessible pet pharmacy solutions. The leadership team includes experienced professionals in logistics, quality assurance, regulatory affairs and information technology, underscoring the company’s commitment to compliance and customer satisfaction. Over more than two decades, PetMed Express has built brand recognition as a trusted resource for pet medications and wellness products.

View PetMed Express Profile

More Earnings Resources from MarketBeat